Infleqtion Inc reports results for the quarter ended June 30 - Earnings Summary
Infleqtion Inc reports results for the quarter ended June 30 - Earnings Summary
Infleqtion Inc INFQ.N reported a quarterly adjusted loss of 5 cents per share for the quarter ended June 30. The mean expectation of three analysts for the quarter was for a loss of 5 cents per share. Wall Street expected results to range from -7 cents to -3 cents per share.
Revenue was $12.63 million; analysts expected $10.64 million.
Infleqtion Inc shares had fallen by 11.3% this quarter and lost 24.2% so far this year.
FORECAST CHANGES
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the electronic equipment & parts peer group is "buy."
Wall Street's median 12-month price target for Infleqtion Inc is $20.00, about 38.2% above its last closing price of $12.36
This summary was machine generated from LSEG data August 12 at 11:21 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | -0.05 | -0.05 | Met |
Recent news on Infleqtion
See all newsBrief: Infleqtion, Honeywell Aerospace And Uc Santa Barbara Collaborate To Accelerate Miniaturization And Manufacturability Of Quantum Hardware
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
Quantum stocks rise after up to $100 million CHIPS awards
U.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion